Brukinsa 160 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AB5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,720
Award facts
- Contract value 100% obligated
- $16,720.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) received a delivery order award from the Defense Logistics Agency valued at $16.7 million for 60-tablet units of Brukinsa 160 mg, a prescription medication used primarily in oncology treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by February 9, 2026, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award carries no set-aside designation and represents a task order under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen's extensive federal contract portfolio demonstrates its critical role as a pharmaceutical distributor to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and military treatment facilities. The company's consistent success in securing delivery orders across multiple therapeutic domains reflects its demonstrated capability to meet federal procurement requirements for specialized medications and medical commodities. This award continues the company's track record of supplying essential pharmaceutical products to support military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1AB5?
SPE2DR26F1AB5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F1AB5 worth?
The government has obligated $16,720 on SPE2DR26F1AB5.
Is contract SPE2DR26F1AB5 an order under another contract?
Yes. SPE2DR26F1AB5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AB5 competed?
The extent of competition for SPE2DR26F1AB5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award